We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+5.19%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$34.1B
AUM Growth
+$362M
Cap. Flow
-$1.11B
Cap. Flow %
-3.25%
Top 10 Hldgs %
15.48%
Holding
3,181
New
192
Increased
947
Reduced
1,799
Closed
170

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$63.9M
2
MSFT icon
Microsoft
MSFT
+$31.4M
3
IBM icon
IBM
IBM
+$23.4M
4
XOM icon
ExxonMobil
XOM
+$23M
5
PFE icon
Pfizer
PFE
+$18.3M

Sector Composition

Rank Sector Weight
1 Financials 14.59%
2 Technology 14.25%
3 Healthcare 13.21%
4 Industrials 11.1%
5 Energy 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SALM
2951
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$121K ﹤0.01%
12,739
+307
+2% +$2.73K
CORT icon
2952
Corcept Therapeutics
CORT
$12.4B
$117K ﹤0.01%
41,885
-1,620
-4% -$4.78K
MPX
2953
DELISTED
Marine Products Corp
MPX
$117K ﹤0.01%
14,125
+118
+0.8% +$891
STM icon
2954
STMicroelectronics
STM
$46.7B
$117K ﹤0.01%
+13,182
New +$123K
ENPH icon
2955
Enphase Energy
ENPH
$4.96B
$116K ﹤0.01%
13,513
+370
+3% +$3K
HIL
2956
DELISTED
Hill International, Inc. Common Stock
HIL
$114K ﹤0.01%
+18,370
New +$117K
NWY
2957
DELISTED
New York & Co Inc
NWY
$114K ﹤0.01%
30,985
+4,658
+18% +$19.4K
YUME
2958
DELISTED
YuMe, Inc.
YUME
$114K ﹤0.01%
+19,375
New +$118K
NYNY
2959
DELISTED
Empire Resorts, Inc.
NYNY
$114K ﹤0.01%
+3,176
New +$109K
MCGC
2960
DELISTED
MCG CAP CORP
MCGC
$112K ﹤0.01%
28,600
-88,639
-76% -$312K
NNVC icon
2961
NanoViricides
NNVC
$38.8M
$111K ﹤0.01%
+1,317
New +$93.5K
VTSS
2962
DELISTED
VITESSE SEMICONDUCTOR CORPORATION COMMON STOCK
VTSS
$110K ﹤0.01%
+31,790
New +$117K
GAIA icon
2963
Gaia
GAIA
$46.8M
$109K ﹤0.01%
+14,200
New +$103K
TLGT
2964
DELISTED
Teligent, Inc
TLGT
$109K ﹤0.01%
+2,054
New +$105K
HNRG icon
2965
Hallador Energy
HNRG
$670M
$108K ﹤0.01%
11,433
+879
+8% +$7.92K
VITC
2966
DELISTED
VITACOST COM INC COM STK (DE)
VITC
$108K ﹤0.01%
17,291
-690
-4% -$4.49K
BEBE
2967
DELISTED
Bebe Stores Inc
BEBE
$107K ﹤0.01%
3,500
-991
-22% -$45.9K
NL icon
2968
NLI Holdings
NL
$281M
$102K ﹤0.01%
11,012
SCMP
2969
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$99K ﹤0.01%
14,408
+1,527
+12% +$10.8K
TLYS icon
2970
Tilly's
TLYS
$116M
$98K ﹤0.01%
+12,127
New +$122K
SYUT
2971
DELISTED
Synutra International, Inc.
SYUT
$96K ﹤0.01%
14,322
-314
-2% -$1.85K
PRKR
2972
DELISTED
Parkervision Inc
PRKR
$90K ﹤0.01%
6,079
-1,162
-16% -$51.9K
PSUN
2973
DELISTED
PACIFIC SUNWEAR OF CAL. INC
PSUN
$90K ﹤0.01%
37,910
-4,984
-12% -$13.3K
LCTX icon
2974
Lineage Cell Therapeutics
LCTX
$269M
$88K ﹤0.01%
35,890
+5,798
+19% +$13.1K
RGLS
2975
DELISTED
Regulus Therapeutics
RGLS
$88K ﹤0.01%
+91
New +$78K

Similar funds

RhumbLine Advisers's Q2 2014 Portfolio in Review

As of Q2 2014, RhumbLine Advisers held 3,181 positions worth $34.1B, up 1.1% from $33.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers withdrew a net $1.11B in Q2 2014, closing 170 positions and reducing 1,799 holdings. Its most notable exit was BEAM INC COM STK (DE), an estimated $18.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in Navient worth $10M.

  • RhumbLine Advisers's largest Q2 2014 buy was Navient: 566,289 shares worth $10M.
  • RhumbLine Advisers added most to American Airlines Group in Q2 2014, an estimated $22.1M increase.
  • RhumbLine Advisers's biggest Q2 2014 reduction was Apple, cutting an estimated $63.9M.
  • RhumbLine Advisers fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $18.3M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $34.1B portfolio in Q2 2014.
  • RhumbLine Advisers opened 192 new positions and closed 170 in Q2 2014.
  • RhumbLine Advisers's portfolio value rose 1.1% quarter-over-quarter to $34.1B.

Based on RhumbLine Advisers's 13F filing for Q2 2014, filed 6 Aug 2014.